In order to confirm the association of LSD1 with breast cancer stem cells, we performed immunohistochemistry for LSD1 and CD44 in a small set (n = 10) of tissue sections from patients with invasive triple-negative breast cancer (TNBC). The gene discussed is CD44; the disease is triple-negative breast carcinoma.